Search results for #biosimilar
The FDA has approved the high-concentrate, citrate-free formulation of subcutaneous adalimumab-adbm (Cyltezo), an interchangeable #biosimilar to #adalimumab (Humira). Learn more: hcplive.com/view/fda-appro…
🇪🇺Dictamen positivo del #CHMP para el #biosimilar 💊Wezenla (ustekinumab) en el tratamiento de la psoriasis en placas (incluida la psoriasis en placas pediátrica), la artritis psoriásica y la enfermedad de Crohn. ema.europa.eu/en/medicines/h…
🇪🇺Dictamen positivo del #CHMP para el #biosimilar 💊Tofidence (tocilizumab) en el tratamiento de la artritis reumatoide, el COVID-19, la artritis idiopática juvenil poliarticular y la artritis idiopática juvenil sistémica. ema.europa.eu/en/medicines/h…
La #FDA está comprometida con el desarrollo y la aprobación continuos de biosimilares de alta calidad, seguros y eficaces y con el mayor acceso que pueden brindar a los pacientes que necesitan tratamientos biológicos. #Biosimilar #FDA #Biológico #FarmayTecnoAM #Seguridad
FDA Approval: Trastuzumab Biosimilar Hercessi for HER2-Overexpressing Cancer Therapy @Pharmacy_Times Read more: vist.ly/34gk9 #Verovian #Recruitment #CancerTherapy #Pharmacy #Biosimilar #USjobs
La formación 📝 del profesional sanitario es fundamental para un cambio exitoso entre original y #biosimilar de #bevacizumab y #trastuzumab 🔄El cambio no afecta a la #seguridad del #paciente #oncológico Este es un ejemplo de evidencia en vida real 👀👇 jhoponline.com/issue-archive/…
Dedicated to innovation, we proudly serve clients across Europe & USA, with our creation of superior biologics and exceptional production efforts. Contact us to discover more about our life-changing developments at zurl.co/RSFW. #biosimilar #biologics #ITP #oncology
The FDA has approved a 150 mg dosage of trastuzumab-strf, a #biosimilar, for the treatment of HER2–over-expressing breast and gastric or gastroesophageal junction adenocarcinoma. #breastcancer #oncology Learn more: ow.ly/qXv350Rsooa
Pharma News: "Cigna subsidiary Evernorth Health Services announced on Thursday that it will offer a Humira (adalimumab) biosimilar with no out-of-pocket cost via its specialty pharmacy Accredo." biospace.com/article/cigna-… #pharmanews #pharmaceuticals #biotech #biosimilar #drugcosts
.@Evernorth's Accredo to offer Humira #biosimilar at $0 out-of-pocket buff.ly/4bcKfOg
Good news for patients! However, bad news for healthcare spending - I am all for market competition that leads to lower prices, but the #humira #biosimilar manipulation by #pbms via private labels = managed competition = crony capitalism @FTC wsj.com/health/pharma/…
🚰 The #PsoriaticArthritis drug pipeline is flowing! Did you miss the latest treatment updates? Don't worry, we've got you covered 🫡 🎧Take a #MedicalMinute⏱️as we break down drug trial data and how the newest #biosimilar may alter patient care routines healio.com/news/rheumatol…
Humira maintained its blockbuster status & market share dominance in Q1 but experienced a drop in sales as biosimilar competition heated up! $ABBV #pharma #rheumatology #dermatology #gastroenterology #biosimilar hubs.li/Q02v9FQN0
The Biosimilars Council continues to dig into FDAs Q&A Draft Promotional Labeling Guidance and we agree: "Once FDA licenses a biosimilar product, including an interchangeable #biosimilar product, HCPs and patients can be confident of the safety and effectiveness of the biosimilar…
The Biosimilars Council continues to dig into FDAs Q&A Draft Promotional Labeling Guidance and we agree: "Once FDA licenses a biosimilar product, including an interchangeable #biosimilar product, HCPs and patients can be confident of the safety and effectiveness of the biosimilar…
The @FDA approved the 50th #biosimilar this week. Congratulations from the Biosimilars Council and the Association for Accessible Medicines and thank you for your hard work and dedication to safe and effective biosimilars medicines. "The FDA is committed to the continued…
failure of the #humira #biosimilar market to take hold shines a bright light on anticompetitive pharma contracting schemes via #pbms that prefer higher $ & larger rebates Worst is the private label schemes via @CVSHealth & @ExpressScripts which will further corrupt competition
failure of the #humira #biosimilar market to take hold shines a bright light on anticompetitive pharma contracting schemes via #pbms that prefer higher $ & larger rebates Worst is the private label schemes via @CVSHealth & @ExpressScripts which will further corrupt competition
#Biosimilar price war update: @Evernorth (@ExpressScripts) $CI launches its own private label Humira w/list "about 85% lower." Twist: Available via Quallent Pharmaceuticals, a Cayman Island-based (!) subsidiary 👀 drugch.nl/3wbRhnv
We’re pleased to share that #Biogen received a positive CHMP opinion from #EMA for a proposed rheumatoid arthritis #biosimilar, based on a robust analytical, non-clinical and clinical data package comparing the product to the reference biologic. Read more: ow.ly/wmu650RosWo